AC Immune S.A.
NASDAQ:ACIUBiotechnology
+$0.04 today
- Market cap
- $214.74M
- Beta
- 1.56
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.67
Volume 0.12M
Average 0.32M
Returns on capital
AC Immune S.A. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-156.8%
avg -31.7%
ROIC
-113.9%
avg -27.0%
ROA
-45.6%
avg -18.1%
Analysis
ROA is currently the strongest return metric at -45.6% versus its period average of -18.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Bojana Portmann | SVP of Intellectual Property,Intellectual Property & Business Development | — | — | — | — |
Francesca Capotosti | Senior Vice President of Research | — | — | — | — |
Gary Anthony Waanders | Senior Vice President of Investor Relations & Corporate Communications | — | 62 | — | — |
Günther Staffler | Executive Vice President of Development | — | 57 | — | — |
Julien Rongere | Senior Vice President of Regulatory Affairs & Quality Assurance | — | 48 | — | — |
Martin Zugel | Interim CEO & Chairman of the Board | — | 63 | — | — |
Matthias Maurer | Senior Vice President & General Counsel | — | 44 | — | — |
Oliver Sol | Vice President & Head of Clinical Development | — | 59 | — | — |
Christopher Roberts | Chief Financial Officer & Vice President of Finance | — | 37 | — | — |
Mark Danton | Executive Vice President of Information Systems & Artificial Intelligence | — | 62 | — | — |
Piergiorgio Donati | Chief Operating Officer | — | 55 | 7.20K | <0.01% |
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 20, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
3
$90,785.00
Net Transaction Value
−$90,785.00
Net selling
Most Active
Pfeifer Andrea
3 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| May 15, 26May 15, 2026 | Pfeifer Andrea Direct | Sell | $27.9K$27,935.00 |
| Apr 15, 26Apr 15, 2026 | Pfeifer Andrea Direct | Sell | $31.4K$31,425.00 |
| Apr 15, 26Apr 15, 2026 | Pfeifer Andrea Direct | Sell | $31.4K$31,425.00 |
Summary
Insiders reported 0 buys worth $0.00 and 3 sells worth $90,785.00 over the last 12 months. That adds up to net selling of $90,785.00. Pfeifer Andrea was the most active insider with 3 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -3.2% | +102.2% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at -3.2% over three years. Forward estimates point to Revenue at +102.2% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does AC Immune S.A. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about ACIU's management, answered from reported figures.
Who manages ACIU?
AC Immune S.A. (ACIU) lists 11 active executives. The top listed executive is Bojana Portmann, SVP of Intellectual Property,Intellectual Property & Business Development.
Are ACIU insiders buying or selling?
Recent insider activity shows net buying of $527,828.44.
Continue the stock analysis
Jump to another research area for this company.